Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2010

Open Access 01-12-2010 | Case report

Reduced uptake of the proliferation-seeking radiotracer technetium-99m-labelled pentavalent dimercaptosuccinic acid in a 47-year-old woman with severe breast epithelial hyperplasia taking ibuprofen: a case report

Authors: Vassilios J Papantoniou, Evangelia K Sotiropoulou, Pipitsa N Valsamaki, Angeliki G Tsaroucha, Maria G Sotiropoulou, Nikolaos D Ptohis, Aikaterini J Stipsanelli, Konstantinos E Dimitrakakis, Spyridon G Marinopoulos, Spyridon T Tsiouris, Aris J Antsaklis

Published in: Journal of Medical Case Reports | Issue 1/2010

Login to get access

Abstract

Introduction

Recent studies have reported a risk reduction in the progression of benign breast disease to breast carcinoma through COX-2 pathways.

Case presentation

We present a case of severe epithelial hyperplasia in a 47-year-old woman with increased breast density submitted to scintimammography by the proliferation-imaging tracer Technetium-99m-labelled pentavalent dimercaptosuccinic acid, before and after an oral ibuprofen treatment for 4 weeks. The radiotracer uptake after ibuprofen intake was significantly reduced, both visually and by semi-quantitative analysis, based on a calculation of lesion-to-background ratios.

Conclusion

In proliferating breast lesions, scintigraphically displayed reduction in Technetium-99m-labelled pentavalent dimercaptosuccinic acid uptake may indicate inhibition by ibuprofen in the pathway of malignant epithelial cell transformation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harris RE, Beebe-Donk J, Alshafie GA: Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer. 2006, 6: 27-10.1186/1471-2407-6-27.CrossRefPubMedPubMedCentral Harris RE, Beebe-Donk J, Alshafie GA: Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer. 2006, 6: 27-10.1186/1471-2407-6-27.CrossRefPubMedPubMedCentral
2.
go back to reference Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC, Helzlsouer KJ: Non-steroidal anti-inflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer. 2006, 106: 1443-1452. 10.1002/cncr.21763.CrossRefPubMed Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC, Helzlsouer KJ: Non-steroidal anti-inflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer. 2006, 106: 1443-1452. 10.1002/cncr.21763.CrossRefPubMed
3.
go back to reference Friedenreich C, Bryant H, Alexander F, Hugh J, Danyluk J, Page D: Risk factors for benign proliferative breast disease. Int J Epidemiol. 2000, 29: 637-644. 10.1093/ije/29.4.637.CrossRefPubMed Friedenreich C, Bryant H, Alexander F, Hugh J, Danyluk J, Page D: Risk factors for benign proliferative breast disease. Int J Epidemiol. 2000, 29: 637-644. 10.1093/ije/29.4.637.CrossRefPubMed
4.
go back to reference Ashbeck EL, Rosenberg RD, Stauber PM, Key CR: Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007, 16: 467-472. 10.1158/1055-9965.EPI-06-0394.CrossRefPubMed Ashbeck EL, Rosenberg RD, Stauber PM, Key CR: Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007, 16: 467-472. 10.1158/1055-9965.EPI-06-0394.CrossRefPubMed
5.
go back to reference Papantoniou V, Tsiouris S, Koutsikos J, Sotiropoulou M, Mainta E, Lazaris D, Valsamaki P, Melissinou M, Zerva C, Antsaklis A: Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy. Nucl Med Commun. 2006, 27: 911-917. 10.1097/01.mnm.0000243367.73141.85.CrossRefPubMed Papantoniou V, Tsiouris S, Koutsikos J, Sotiropoulou M, Mainta E, Lazaris D, Valsamaki P, Melissinou M, Zerva C, Antsaklis A: Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy. Nucl Med Commun. 2006, 27: 911-917. 10.1097/01.mnm.0000243367.73141.85.CrossRefPubMed
6.
go back to reference Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F: Correlation between 99 mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Cancer Biother Radiopharm. 2005, 20: 249-259. 10.1089/cbr.2005.20.249.CrossRefPubMed Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F: Correlation between 99 mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Cancer Biother Radiopharm. 2005, 20: 249-259. 10.1089/cbr.2005.20.249.CrossRefPubMed
7.
go back to reference Papantoniou VJ, Souvatzoglou MA, Valotassiou VJ, Louvrou AN, Ambela C, Koutsikos J, Lazaris D, Christodoulidou JK, Sotiropoulou MG, Melissinou MJ, Perperoglou A, Tsiouris S, Zerva CJ: Relationship of cell proliferation (Ki-67) to 99 mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res. 2004, 6: R56-R62. 10.1186/bcr751.CrossRefPubMed Papantoniou VJ, Souvatzoglou MA, Valotassiou VJ, Louvrou AN, Ambela C, Koutsikos J, Lazaris D, Christodoulidou JK, Sotiropoulou MG, Melissinou MJ, Perperoglou A, Tsiouris S, Zerva CJ: Relationship of cell proliferation (Ki-67) to 99 mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res. 2004, 6: R56-R62. 10.1186/bcr751.CrossRefPubMed
8.
go back to reference Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, Nakopoulou L, Lazaris D, Louvrou A, Melissinou M, Tzannetaki A, Pirmettis I, Koutsikos J, Zerva C: Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res. 2005, 7: R33-R45. 10.1186/bcr948.CrossRefPubMed Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, Nakopoulou L, Lazaris D, Louvrou A, Melissinou M, Tzannetaki A, Pirmettis I, Koutsikos J, Zerva C: Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res. 2005, 7: R33-R45. 10.1186/bcr948.CrossRefPubMed
9.
10.
go back to reference Papantoniou V, Sotiropoulou E, Tsiouris S, Ptohis N, Sotiropoulou M, Tsigris A, Stipsanelli A, Sirgiannis K, Dimitrakakis K, Valsamaki P, Kounadi E, Makris N, Zerva C, Antsaklis A: Correlation of mammographic density with the mode of scintimammographic 99 mTc-(V)DMSA uptake in various breast pathologies [abstract]. EJNMMI. 2007, 34: s306- Papantoniou V, Sotiropoulou E, Tsiouris S, Ptohis N, Sotiropoulou M, Tsigris A, Stipsanelli A, Sirgiannis K, Dimitrakakis K, Valsamaki P, Kounadi E, Makris N, Zerva C, Antsaklis A: Correlation of mammographic density with the mode of scintimammographic 99 mTc-(V)DMSA uptake in various breast pathologies [abstract]. EJNMMI. 2007, 34: s306-
Metadata
Title
Reduced uptake of the proliferation-seeking radiotracer technetium-99m-labelled pentavalent dimercaptosuccinic acid in a 47-year-old woman with severe breast epithelial hyperplasia taking ibuprofen: a case report
Authors
Vassilios J Papantoniou
Evangelia K Sotiropoulou
Pipitsa N Valsamaki
Angeliki G Tsaroucha
Maria G Sotiropoulou
Nikolaos D Ptohis
Aikaterini J Stipsanelli
Konstantinos E Dimitrakakis
Spyridon G Marinopoulos
Spyridon T Tsiouris
Aris J Antsaklis
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2010
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-4-89

Other articles of this Issue 1/2010

Journal of Medical Case Reports 1/2010 Go to the issue